Wall Street set for muted open as investors await business survey data

Reuters

Wall Street set for muted open as investors await business survey data

Jun 21, 2024 at 1:16 pm GMT

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street set for muted open as investors await business survey data</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

Spirit Aero up following report of Boeing nearing buyout deal

Sarepta surges on expanded use of gene therapy

Gilead gains after long-acting HIV drug trial success

S&P 500 crossed 5,500 points on Thursday

Futures down: Dow 0.12%, S&P 500 0.08%, Nasdaq 0.01%

Updated at 8:45 a.m. ET/1245 GMT

By Lisa Pauline Mattackal and Ankika Biswas

June 21 (Reuters) -Wall Street was set for a muted open on Friday as chip stocks lost ground, with focus on data from the manufacturing and services sectors for more clues on the health of the world's largest economy.

The S&P 500 .SPX crossed the 5,500 point milestone during Thursday's session, however, both the benchmark index and the tech-heavy Nasdaq .IXIC closed lower as megacap stocks pulled back.

AI chip firm Nvidia NVDA.O dropped 1.7% in premarket trading on Friday, after losses in the previous session saw its market valuation fall back below that of Microsoft MSFT.O.

Semiconductor stocks Qualcomm QCOM.O, Micron Technology MU.O and Arm Holdings ARM.O were down between 0.8% and 3.4%, while megacaps such as Microsoft and Apple AAPL.O rose 0.1% and 0.3%, respectively.

Wall Street's bumper gains since the final leg of 2023 have been primarily driven by the likes of Nvidia and a handful of other heavily weighted stocks linked to artificial intelligence. Analysts, however, have flagged whether the strong increase in their valuations is sustainable.

"The largest companies in the S&P 500 are excellent, very profitable and growing quickly ... but they are getting a little bit expensive," said Chris Zaccarelli, chief investment officer at Independent Advisor Alliance.

"We wouldn't be surprised if the market takes a breather and cools off a bit in the short term."

Investors are also assessing a string of weakening economic data and commentary from U.S. Federal Reserve officials that interest rates could remain higher for longer if there is no consistent improvement in inflation numbers.

Later in the day, focus will be on flash S&P PMI readings, that are expected to fall slightly, but remain above the 50 level that shows activity is still expanding. Existing housing sales data is on tap as well.

Friday's session will also mark the expiry of quarterly derivatives contracts tied to stocks, index options and futures, also known as "triple witching".

All three major Wall Street stock indexes are set to close the week higher, as is the small-cap focused Russell 2000 .RUT.

Money markets are pricing in a 58% chance of a 25-basis point interest rate cut at the Fed's meeting in September, and still expect about two rate cuts this year, according to LSEG's FedWatch data. FEDWATCH

At 8:45 a.m. ET, Dow e-minis 1YMcv1 were down 47 points, or 0.12%, S&P 500 e-minis EScv1 were down 4.5 points, or 0.08%, and Nasdaq 100 e-minis NQcv1 were down 1.75 points, or 0.01%.

Spirit AeroSystems SPR.N jumped 4.5% following a Reuters report that Boeing BA.N is nearing a deal to buy back the airplane parts supplier after months of talks.

Drugmaker Gilead GILD.O jumped 3.0%, extending gains from Thursday as a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill Truvada.

Sarepta Therapeutics SRPT.O soared 33.2% after the U.S. Food and Drug Administration allowed the expanded use of the company's gene therapy for patients with Duchenne muscular dystrophy aged four and older.

Reporting by Lisa Mattackal and Ankika Biswas in Bengaluru; Editing by Shounak Dasgupta

</body></html>